Vi­gene Bio­sciences goes big on Mary­land vi­ral vec­tor ex­pan­sion as it rides high on Al­tim­mune vac­cine deal

Boost­ed by a gang­busters year for Rockville-based Emer­gent BioSo­lu­tions and its vi­ral vec­tors for Covid-19 vac­cines, the state of Mary­land has con­tin­ued to ce­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.